13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001447228
Total reported value
$291.3M
$291.3M
24 檔
127.6%
The Q4 2025 SEC filing reveals that Yiheng Capital Management, L.P. held a total portfolio value of $291.3M, covering 24 public equity positions.
In Q4 2025, Yiheng Capital Management, L.P. adopted a defensive or profit-taking posture, trimming 11 positions and completely liquidating 4 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALAB | Astera Labs Inc | Stock-Tech | 48.04% | — | — | |
| 2 | NOAH | Noah Holdings Ltd-spon Ads | Stock-Other | 13.64% | -5.79% | — | |
| 3 | BILI | Bilibili Inc-sponsored Adr | Stock-Other | 5.72% | +5.11% | -36.82% | |
| 4 | JD | Jd.com Inc-adr | Stock-Consumer Disc | 3.99% | +5.02% | -73.58% | |
| 5 | EDU | New Oriental Educatio-sp Adr | Stock-Consumer Staples | 3.79% | +1.79% | -34.73% | |
| 6 | HTHT | H World Group Ltd-adr | Stock-Other | 3.79% | -2.42% | -12.84% | |
| 7 | RERE | Atrenew Inc | Stock-Other | 3.39% | -2.23% | — | |
| 8 | VSAT | Viasat Inc | Stock-Tech | 3.18% | — | -38.06% | |
| 9 | DBVT | Dbv Technologies Sa-spon Adr | Stock-Other | 2.48% | -0.58% | -2.52% | |
| 10 | ULS | Ul Solutions Inc - Class A | Stock-Industrials | 2.39% | — | — | |
| 11 | PONY | Pony Ai Inc | Stock-Other | 1.92% | -1.11% | +226.12% | |
| 12 | ACMR | Acm Research Inc-class A | Stock-Other | 1.39% | — | -37.74% | |
| 13 | VRDN | Viridian Therapeutics Inc | Stock-Other | 1.31% | +0.76% | -58.27% | |
| 14 | KYMR | Kymera Therapeutics Inc | Stock-Other | 1.16% | -0.15% | -40.10% | |
| 15 | SVCO | Silvaco Group Inc | Stock-Other | 0.90% | +0.93% | — | |
| 16 | YMM | Full Truck Alliance -spn Adr | Stock-Other | 0.89% | -0.42% | — | |
| 17 | TAL | Tal Education Group- Adr | Stock-Consumer Staples | 0.68% | -1.25% | — | |
| 18 | API | Agora Inc-adr | Stock-Other | 0.44% | -0.12% | — | |
| 19 | YSG | Yatsen Holding Ltd-adr | Stock-Other | 0.29% | -0.04% | +282.39% | |
| 20 | IVA | Inventiva SA - Adr | Stock-Other | 0.24% | — | -90.32% | |
| 21 | ✓ | Stock-Other | 0.12% | — | — | ||
| 22 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.12% | +0.03% | -69.41% | |
| 23 | PASG | Passage Bio Inc | Stock-Other | 0.08% | -0.15% | — | |
| 24 | TOUR | Tuniu Corp-spon Adr | Stock-Other | 0.04% | -0.10% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALAB | Astera Labs Inc | +6.8% | — | Unchanged |
| 2 | NOAH | Noah Holdings Ltd-spon Ads | +2.2% | — | Unchanged |
| 3 | DBVT | Dbv Technologies Sa-spon Adr | +1.5% | -2.52% | Trim |
| 4 | PONY | Pony Ai Inc | +1.3% | +226.12% | Add |
| 5 | RERE | Atrenew Inc | +1.2% | — | Unchanged |
| 6 | HTHT | H World Group Ltd-adr | +1.2% | -12.84% | Trim |
| 7 | TAL | Tal Education Group- Adr | +0.2% | — | Unchanged |
| 8 | YSG | Yatsen Holding Ltd-adr | +0.2% | +282.39% | Add |
| 9 | KYMR | Kymera Therapeutics Inc | +0.1% | -40.10% | Trim |
| 10 | API | Agora Inc-adr | +0.1% | — | Unchanged |
| 11 | SVCO | Silvaco Group Inc | 0% | — | Unchanged |
| 12 | ✓ | 0% | — | Unchanged | |
| 13 | VSAT | Viasat Inc | — | -38.06% | Trim |
| 14 | TOUR | Tuniu Corp-spon Adr | — | — | Unchanged |
| 15 | BEAM | Beam Therapeutics Inc | -0.1% | -69.41% | Trim |
| 16 | ACMR | Acm Research Inc-class A | -0.2% | -37.74% | Trim |
| 17 | VRDN | Viridian Therapeutics Inc | -0.3% | -58.27% | Trim |
| 18 | EDU | New Oriental Educatio-sp Adr | -0.3% | -34.73% | Trim |
| 19 | BILI | Bilibili Inc-sponsored Adr | -1.8% | -36.82% | Trim |
| 20 | IVA | Inventiva SA - Adr | -2% | -90.32% | Trim |
| 21 | JD | Jd.com Inc-adr | -9.4% | -73.58% | Trim |
| 22 | ULS | Ul Solutions Inc - Class A | — | NEW | New buy |
| 23 | AKRO | Akero Therapeutics Inc | — | EXIT | Sold out |
| 24 | DNLI | Denali Therapeutics Inc | — | EXIT | Sold out |
| 25 | RARE | Ultragenyx Pharmaceutical In | — | EXIT | Sold out |
| 26 | YMM | Full Truck Alliance -spn Adr | — | NEW | New buy |
| 27 | CLBT | Cellebrite DI Ltd. | — | EXIT | Sold out |
| 28 | PASG | Passage Bio Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Yiheng Capital Management, L.P. reported a total U.S. public equity portfolio value of $291.3M across 24 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALAB, NOAH, BILI) accounted for 127.6% of total reported equity market value during Q4 2025.
Top New Position Initiated
ULS
市值: $11.8M
Top Position Liquidated / Trimmed
AKRO
前期市值: $9.1M
During Q4 2025, Yiheng Capital Management, L.P.'s top holdings by market value included ALAB (48.0%)、NOAH (13.6%)、BILI (5.7%). The largest single position, ALAB, represented 48.0% of total portfolio value.
In Q4 2025, Yiheng Capital Management, L.P. made 20 total portfolio adjustments, initiating 3 new buys, adding to 2 positions, trimming 11 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.